ALL >> Health >> View Article
Forecast Insight: Antidiabetics - Switching To New Molecule Antidiabetics Drives Market Growth
It expects the antidiabetics market to reach $29 billion, across the seven major markets, by 2017. The growth will be driven by the launch of new drug classes, notably the DPP-IV inhibitors and GLP-1 agonists, and large growth in patient numbers. However, patent expiries of the glitazone (TZDs) class will restrain market growth.
Scope of this report
Description of the competitive landscape in antidiabetics across seven major markets with market definition and overview.
Event-driven updated sales forecasts for 2008-17 across the seven major markets: US, France, Germany, Italy, Spain, UK and Japan.
Analysis of major events and brand dynamics affecting the diabetes market.
Research and analysis highlights
The antidiabetics market in the seven major markets is expected to grow from $18 billion in 2007 to $29 billion in 2017 at a rate of 5% CAGR. Significant unmet needs remain in diabetes fueling a large pipeline. The epidemiological growth of the market, driven by the obesity epidemic and improved diagnosis rates, is further driving the market.
The glitazone class was the major ...
... non-insulin antidiabetic therapy in 2007 driven by the Actos and Avandia franchises. Both of these drugs will lose their marketing leading positions following patent expiry in 2011 and 2013. Safety concerns over Avandia remain unresolved and the drug will continue to continue to lose market share.
The incretin mimetics are likely to be the beneficiaries of Avandia's problems and the DPP-IV inhibitors are expected to become the leading non-insulin antidiabetics. GLP-1 agonists are also expected to record significant sales. The two classes will provide over 75% of the sales from newly launched antidiabetics.
Key reasons to read this report
Quantify the future size of the antidiabetics market and identify opportunities for new products.
Learn how product expiries will shape the antidiabetics market.
Understand the barriers to uptake for novel antidiabetic agents, and the implications of recent regulatory reviews.
For more information Kindly visit the website : http://www.bharatbook.com/detail.asp?id=83048
Or Contact us on :
Tel No : (+9122 )27578668 , 27579438
Fax: (+9122 )27579131
Address :
Bharat Book Bureau,
207,Hermes Atrium,
Sector-11
P.O Box 54,
CBD Belapur,
Navi Mumbai - 400614.
Add Comment
Health Articles
1. Transform Your 2025 New Year’s Resolution With YogaAuthor: Yog Kosha
2. Tooth Extractions In Surat: Costs, Procedures, And Expert Care
Author: Elegance Clinic
3. Navigating The Best Urology & Kidney Care In Chennai
Author: prakash
4. The Impact Of Stress On Women’s Reproductive Health
Author: Dr Pankaj Lodha
5. Understanding Hernia Surgery Costs And Finding The Best Hernia Surgeon In Chennai
Author: ganesh
6. Best Nephrology Hospital In Hyderabad
Author: PACE
7. Are Dental Implants Safe? How Dental Implants Work: Procedure And Recovery Timeline !
Author: Riverplace Periodontics
8. Can Frontline Spray Be Used On Cats?
Author: VetSupply
9. Kids Smiles Dentistry
Author: Dr. Jina Rasouli
10. The Road To Marriage: Why Pre-marital Counselling Is Key To Relationship Success
Author: Arnav Arora
11. Best Hospital In Pune - Onp Prime Hospital
Author: Prisha Patil
12. Psychological Safety: The Key To Thriving Teams And Innovation
Author: Linda Ray
13. Best Dental Clinic In South Delhi
Author: Dental Arche
14. Are Greenies Dental Treats Good For Dogs?
Author: VetSupply
15. Is Osteocare Good For Dogs?
Author: VetSupply